Monday, 14th November Australian Society for Medical Research Annual Scientific Meeting 2016
Symposium 3 - Disease detection & optimising treatment
9:00AM - 10:35AM
Monday, 14th November
Theatre 4 Building 6
Chair: Brigid Lynch
Sponsored by:
- Understanding the population level scenario in disease progression and personalised management of disease - The need for a big national level primary care database - Sanjoy Paul
- Multiplexing DNA Binding Chemistry Based Assay with the Use of Digital PCR for GAEC1 Copy Number Variation Identification in Colorectal Cancer - Katherine Lee
- Interleukin 1 Beta Variance is Predictive of Chemotherapy-induced Gastrointestinal Toxicity (CIGT) Risk in Patients Receiving 5-fluorouracil. - Samantha K Korver
- Circulatory microRNAs for the early diagnosis of liver cirrhosis and hepatocellular carcinoma in chronic Hepatitis C - Anna Weis
- High resolution mass spectrometry to identify new colorectal cancer biomarkers from sequentially collected plasma samples - Juhura (Trisha) G Al-mazi
- Breath Test for Head and Neck Cancer: A Novel and Non-Invasive Approach - Dhinashini DC Chandran
Morning Tea
10:35AM - 11:00AM
Monday, 14th November
Basil Seller Foyer
ASMR Research Fund Meeting
10:30AM - 11:00AM
Monday, 14th November
Theatre 4 Building 6
Firkin Oration
11:00AM - 12:00PM
Monday, 14th November
Theatre 4 Building 6
Chair: Dan Johnstone
Sponsored by:
Lunch
12:00PM - 12:45PM
Monday, 14th November
Basil Seller Foyer
ASMR Annual General Meeting
12:30PM - 1:30PM
Monday, 14th November
Theatre 4 Building 6
Poster Session 2
12:45PM - 2:00PM
Monday, 14th November
Basil Seller Foyer
Symposium 4 - Nanotechnology, drug delivery, new drugs and targets
2:00PM - 3:35PM
Monday, 14th November
Theatre 4 Building 6
Chair: Phoebe Phillips
- Engineering Particles for Nanomedicine Applications - Frank Caruso
- Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma - Belamy B. Cheung
- Novel Drug Delivery Platform for the Topical Treatment of Cancer - Yaman Tayyar
- A proteogenomic approach to identify new drug targets for acute myeloid leukaemia - Matthew D Dun
- Design, Development and Characterization of Synthetic Electrospun Nanofibrous Membranes for Retinal Pigmented Epithelium Cells - Denver C Surrao
- Mathematical modelling of applanation tonometry for intraocular pressure measurements. - Andrei M Ermakov
Afternoon Tea
3:35PM - 4:00PM
Monday, 14th November
Basil Seller Foyer
Symposium 5 - Monitoring of disease progression & therapeutic response
4:00PM - 5:35PM
Monday, 14th November
Theatre 4 Building 6
Chair: Joanne Bowen
Sponsored by:
- The relevance or not of biomarkers to clinical outcomes; whose agenda? - Jennifer Martin
- Hypertension impairs cognitive function and exacerbates amyloid-β pathology in Alzheimer’s transgenic APP/PS1 mouse model - Jie Liu
- Assessing skeletal muscle bioenergetics in situ: characterising metabolic perturbations in a mouse model of motor neuron disease - Rui Li
- Real time assessment of altered signalling pathways in the pathobiology of Chronic Obstructive Pulmonary Disease - David Skerrett-Byrne
- Botulinum toxin for Foot Dystonia in Patients with Parkinson's Disease having Deep Brain Stimulation: A Case series and a Pilot study. - Anupam Datta Gupta
- Acute malaria reveals differential roles for programmed death-1 (PD-1) and its ligands in T cell-mediated protection - Joshua Horne-Debets
Social Function: Conference BBQ
5:35PM - 7:45PM
Monday, 14th November
ADCO Amphitheatre